Ten-year experience with extended criteria cardiac transplantation
- PMID: 24088293
- PMCID: PMC4618320
- DOI: 10.1161/CIRCHEARTFAILURE.113.000296
Ten-year experience with extended criteria cardiac transplantation
Abstract
Background: Extended criteria cardiac transplant (ECCT) programs expand the transplant pool by matching donors and recipients typically excluded from the transplant process because of age or comorbidity. There is a paucity of data examining long-term outcomes with this strategy.
Methods and results: Between January 2000 and December 2009, adult patients undergoing isolated heart transplant were prospectively classified as ECCT based on prespecified criteria. Baseline characteristics and outcomes were compared between ECCT and standard criteria cardiac transplant recipients. Two Cox proportional hazards models were developed. The first to identify clinical variables contributing to survival between the 2 groups, and the second to determine the additional risk associated with assignment to ECCT. Among the 454 patients who underwent heart transplant, 84 (18.5%) were ECCT. Compared with the patients who underwent standard criteria cardiac transplant, ECCT patients were older (median, 66.6 years versus 53.2 years; P<0.001), with higher frequency of diabetes mellitus (46.4% versus 24.6%; P<0.001) and chronic kidney disease (median estimated glomerular filtration rate, 55 versus 61.6 mL/min; P=0.001). After adjustment for baseline characteristics, standard criteria cardiac transplant survival was higher than ECCT at 1 (89% versus 86%; P=0.18) and 5 (77% versus 66%; P=0.035) years. In a multivariate model that included listing criteria, creatinine (hazard ratio, 1.05 per 0.1 mg/dL; 95% confidence interval, 1.02-1.09; P=0.001) was a significant predictor of post-transplant mortality.
Conclusions: ECCT is an acceptable alternative for advanced heart failure therapy in select patients. Age and renal dysfunction are important determinants of long-term survival and post-transplant morbidity.
Keywords: heart failure; survival; transplantation.
Figures
References
-
- Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The registry of the international society for heart and lung transplantation: Twenty-eighth adult heart transplant report—2011. The Journal of Heart Lung Transplantation. 2011;30:10781094. - PubMed
-
- Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D’Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M. Consensus conference report. Circulation. 2002;106:836–841. - PubMed
-
- Felker GM, Milano CA, Yager JEE, Hernandez AF, Blue L, Higginbotham MB, Lodge AJ, Russell SD. Outcomes with an alternate list strategy for heart transplantation. The Journal of Heart and Lung Transplantation. 2005;24:1781–1786. - PubMed
-
- Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. The New Englland Journal of Medicine. 2001;345:1435–1443. - PubMed
-
- Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN., III Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: Results of the intrepid trial. Journal of the American College of Cardiology. 2007;50:741–747. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
